Monday, February 26

South Africa Sells 1 Million Doses of Astrazeneca to 14 Other African Countries

South Africa has sold one million doses of the AstraZeneca vaccine to 14 other African countries.


South Africa no longer wants the vaccine itself because, according to a study, it would not work sufficiently against the South African variant of the coronavirus.

South Africa suspended its COVID-19 vaccination campaign in mid-February. In principle, this would happen with the AstraZeneca vaccine. Still, according to a study by a university in Johannesburg, the AstraZeneca vaccine has only “limited” effectiveness against the South African variant of the coronavirus.

However, experts from the World Health Organization (WHO) see no problem in using the AstraZeneca vaccine in countries where variants of the coronavirus are circulating.

But the South African government said after the study that it would propose the doses to the African Union. It came up with several countries, but South Africa wanted guarantees that the necessary conditions were available in the countries concerned to organize a vaccination campaign. The country has now received “the full amount” of the sale, the South African health minister said.

South Africa is most affected by COVID-19 on the African continent, with more than 52,000 dead. The country has now ordered vaccines from Johnson & Johnson and Pfizer / BioNTech, intending to vaccinate two-thirds of its 59 million population.

At present, only 183,000 people have been vaccinated. The coronavirus epidemic has slowed considerably in recent times, with another thousand new infections per day.

Leave a Reply